Key Themes & Topics
Geopolitics & The Biosecure Arbitrage
A strategic deep dive into the U.S. Biosecure Act: How European companies can legally and ethically leverage the "Buyer’s Market" for high-quality Asian capacity.
The "Dual-Shore" Manufacturing Model
Architecting hybrid supply chains that combine European "Quality Anchors" (IP/Release) with Asian "Speed Engines" (Commercial Bulk).
Trust Architecture & Risk Management
Building robust oversight frameworks including "Man-in-the-Plant" models, IP escrow, and real-time data mirroring to mitigate the trust deficit.
Cost Optimisation & Procurement Strategy
Balancing "Total Landed Cost" vs. Speed. Analysing the economics of outsourcing commoditised biologics vs. complex modalities
WHO
For CPOs, Heads of External Supply, and Procurement Directors looking to optimise their CDMO network and navigate geopolitical risks.
WHAT
The strategic forum for Sino-European partnerships, dedicated to building secure, cost-effective, and trusted outsourcing relationships in a post-Biosecureworld.
WHY
To master the "Speed vs. Trust" equation: accessing Asian capacity to accelerate timelines while maintaining strict European compliance and IP security.
Senior Attendees
Meet a concentrated audience of CPOs, Heads of External Supply, and Procurement Directors navigating the complexities of the global CDMO market.
Expert Speakers
Hear from world-class leaders in geopolitical strategy, supply chain risk management, and legal compliance regarding the Biosecure Act and Sino-European partnerships.
Companies Represented
A strategic gathering representing European big pharma buyers, "China Champion" CDMOs, legal consultancies, and supply chain audit firms.
Networking Hours
Connect with potential partners to discuss contract structures, IP security, and the future of cost-effective, high-quality outsourcing models.
